← Leaderboards
Christopher A Maher
Washington University
$7,094,981
Attributed
$10,846,935
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,846,935 · 9
By mechanism
R01$9,639,866 · 6
R00$684,518 · 1
R21$314,532 · 1
K99$208,019 · 1
Top collaborators
- Ryan C Fields5 shared
- Jingqin Luo4 shared
- Jeff P Simko4 shared
- Aadel Chaudhuri2 shared
- Russell K. Pachynski2 shared
- Katherine Nelson Weilbaecher1 shared
Most similar at Washington University
Same institution · by research overlap
- Helen M Piwnica-Worms$9,529,923
- Aadel Chaudhuri$3,906,206
- Ryan C Fields$14,321,445
- Jeff P Simko$5,715,983
- Jieya Shao$4,238,034
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorCohortGenesTranscriptome SequencingMalignant NeoplasmsTissuesCancer TherapyNeoplasm MetastasisPhenotypeGene ExpressionMonitorTranslational ImpactCellsSamplingSiteInsightIn VivoIn VitroPrimary NeoplasmTherapeutic TargetCodeRegulationOncogenicTumor Biology
Grant awards (30)
Mechanism of acid signaling in bone organ metastases on tumor and myeloid cell evolution towards immune suppression and tumor progression$645,323
R01 · FY2025 · CA
Molecular Biomarkers of Long-Term Response to Androgen Deprivation Therapy and Radiation in Prostate Cancer$633,122
R01 · FY2025 · CA · contact PI
Novel ctDNA biomarker for androgen therapy in metastatic prostate cancer$610,019
R01 · FY2025 · CA · contact PI
The role of RAMS11 in colorectal cancer progression and treatment resistance$544,644
R01 · FY2025 · CA · contact PI
Understanding the role of RAMS11 in non small cell lung cancer$355,706
R01 · FY2025 · CA · contact PI
The role of RAMS11 in colorectal cancer progression and treatment resistance$85,153
R01 · FY2025 · CA · contact PI
Molecular Biomarkers of Long-Term Response to Androgen Deprivation Therapy and Radiation in Prostate Cancer$608,488
R01 · FY2024 · CA · contact PI
Novel ctDNA biomarker for androgen therapy in metastatic prostate cancer$596,475
R01 · FY2024 · CA · contact PI
The role of RAMS11 in colorectal cancer progression and treatment resistance$545,341
R01 · FY2024 · CA · contact PI
The role of RAMS11 in colorectal cancer progression and treatment resistance$85,153
R01 · FY2024 · CA · contact PI
Molecular Biomarkers of Long-Term Response to Androgen Deprivation Therapy and Radiation in Prostate Cancer$636,570
R01 · FY2023 · CA · contact PI
The role of RAMS11 in colorectal cancer progression and treatment resistance$567,677
R01 · FY2023 · CA · contact PI
Molecular Biomarkers of Long-Term Response to Androgen Deprivation Therapy and Radiation in Prostate Cancer$673,467
R01 · FY2022 · CA · contact PI
The role of RAMS11 in colorectal cancer progression and treatment resistance$558,058
R01 · FY2022 · CA · contact PI
The role of RAMS11 in colorectal cancer progression and treatment resistance$551,689
R01 · FY2021 · CA · contact PI
THE ROLE OF POLYCOMB ASSOCIATED LONG NON-CODING RNAS IN LUNG CANCER METASTASIS$348,844
R01 · FY2021 · CA · contact PI
THE ROLE OF POLYCOMB ASSOCIATED LONG NON-CODING RNAS IN LUNG CANCER METASTASIS$348,844
R01 · FY2020 · CA · contact PI
THE ROLE OF POLYCOMB ASSOCIATED LONG NON-CODING RNAS IN LUNG CANCER METASTASIS$338,378
R01 · FY2019 · CA · contact PI
THE ROLE OF POLYCOMB ASSOCIATED LONG NON-CODING RNAS IN LUNG CANCER METASTASIS$91,156
R01 · FY2019 · CA · contact PI
THE ROLE OF POLYCOMB ASSOCIATED LONG NON-CODING RNAS IN LUNG CANCER METASTASIS$348,844
R01 · FY2018 · CA · contact PI
THE ROLE OF POLYCOMB ASSOCIATED LONG NON-CODING RNAS IN LUNG CANCER METASTASIS$93,177
R01 · FY2018 · CA · contact PI
THE ROLE OF POLYCOMB ASSOCIATED LONG NON-CODING RNAS IN LUNG CANCER METASTASIS$24,894
R01 · FY2018 · CA · contact PI
THE ROLE OF POLYCOMB ASSOCIATED LONG NON-CODING RNAS IN LUNG CANCER METASTASIS$348,844
R01 · FY2017 · CA · contact PI
CLONAL EVOLUTION OF STRUCTURAL VARIANTS IN THE PROGRESSION OF METASTATIC COLORECT$142,969
R21 · FY2015 · CA · contact PI
CLONAL EVOLUTION OF STRUCTURAL VARIANTS IN THE PROGRESSION OF METASTATIC COLORECT$171,563
R21 · FY2014 · CA · contact PI
Characterization of Cancer Transcriptomes using Next Generation Sequencing$211,158
R00 · FY2013 · CA · contact PI
Characterization of Cancer Transcriptomes using Next Generation Sequencing$231,830
R00 · FY2012 · CA · contact PI
Characterization of Cancer Transcriptomes using Next Generation Sequencing$241,530
R00 · FY2011 · CA · contact PI
Characterization of Cancer Transcriptomes using Next Generation Sequencing$105,068
K99 · FY2011 · CA · contact PI
Characterization of Cancer Transcriptomes using Next Generation Sequencing$102,951
K99 · FY2010 · CA · contact PI